ReviewFoods (Basel, Switzerland)2026
Identifying Key Bioactive Components in Postbiotic Preparations: From Candidate Discovery to Functional Validation.
Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Postbiotic preparations contain inanimate microbial cells and a diverse mixture of cell-wall structures, proteins, polysaccharides, lipids, metabolites, and vesicle-associated materials. Although many of these components have been proposed as key bioactives, most are identified through compositional profiling, enrichment in active fractions, or testing of purified molecules. Such findings demonstrate biological activity but do not necessarily show that a candidate contributes to the effect of the original preparation. This review examines the experimental approaches used to narrow candidate lists and evaluate functional contribution, including phenotype-guided comparison, activity-guided fractionation, selective depletion, multi-omics profiling, structural characterization, dose-response testing, mechanistic intervention, and reconstitution. A structured narrative search of Web of Science Core Collection, PubMed, and Scopus through 30 March 2026, supplemented by citation tracking, identified the relevant literature; 15 representative primary studies that examined defined candidates and provided evidence beyond compositional detection were selected and appraised across seven preparation-level attribution domains. An appraisal of representative studies shows that current evidence largely supports the activity of individual candidates, whereas preparation-level attribution remains uncommon. Stronger evidence requires quantification of the candidate in the source material, selective removal with appropriate controls, and restoration at a preparation-relevant dose. Structural heterogeneity, processing history, molecular state, dose, and experimental context must also be considered. This evidence-based approach can support bioactive-component validation, batch consistency, and the design of future preclinical and human studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.